EUVIMEDEUVIMED entdecken
Crossref

The benefits of adjuvant chemotherapy are associated with the kind of neoadjuvant therapy in stage ypI rectal cancer: evidence based on population analysis

Hualin Liao, Tao Li, Yahang Liang, Yaxiong Liu, Yuli Yuan, Mingming Li, Aidi Li, Yang Liu, Yao Yao, Taiyuan Li

International Journal of Colorectal Disease · 2023

DOI: 10.1007/s00384-023-04530-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Colorectal Disease, 2023. Verfasst von Hualin Liao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoplasms, Second Primary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The oncological role of adjuvant chemotherapy (ACT) remains debated in locally advanced rectal cancer (RC) after neoadjuvant therapy (NAT), especially ypI RC. In this study, we used population-based data to evaluate the benefits of ACT in stage ypI RC after NAT and surgery. Moreover, we tried to differentiate what kind of NAT (radiotherapy alone or chemoradiotherapy) was administered because this may affect the further efficacy of ACT. METHODS: All patients with stage ypI primary rectal malignancy were diagnosed in the SEER database between 2004 and 2017. The Kaplan-Meier method was applied to estimate the effects of ACT in survival analysis. Cox regression was performed to calculate the hazard ratio (HR) and the prognosis factors of survival. Propensity score matching (PSM) was used to balance the parameters between therapy groups. RESULTS: The overall cohort's median follow-up time was 105 months. For 5-year OS and CSS, there were no significant differences between the ACT ( +) and ACT (-) groups (p = 0.105; p = 0.788). However, subgroup analyses according to the kind of NAT found that ACT improved overall survival (OS) and cancer-specific survival (CSS) in patients who received neoadjuvant radiotherapy (nRT) (p < 0.001, p = 0.015). Among patients who received neoadjuvant chemoradiotherapy (nCRT), no significant survival benefits were found between the ACT ( +) and ACT (-) groups (p = 0.526, p = 0.288). CONCLUSION: Our population-based cohort study suggested that the efficacy of ACT was associated with the kind of NAT. The ACT provides survival benefits in stage ypI RC for patients who received nRT. However, among patients who received nCRT, ACT did not improve long-term survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoplasms, Second PrimaryHumansCohort StudiesNeoadjuvant TherapyChemotherapy, AdjuvantChemoradiotherapy

Stichwörter der Autor:innen

Adjuvant chemotherapyNeoadjuvant therapyRectal cancerSurvival, Stage ypI

Autor:innen und Institutionen

  • Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.
  • Gastrointestinal Surgical Institute, Nanchang University, Nanchang, 330006, Jiangxi, China.
  • Department of General Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China. jylitaiyuan@163.com.
  • Gastrointestinal Surgical Institute, Nanchang University, Nanchang, 330006, Jiangxi, China. jylitaiyuan@163.com.

Zitieren

APA

Liao, H., Li, T., Liang, Y., Liu, Y., Yuan, Y., Li, M., Li, A., Liu, Y., Yao, Y., & Li, T. (2023). The benefits of adjuvant chemotherapy are associated with the kind of neoadjuvant therapy in stage ypI rectal cancer: evidence based on population analysis. International Journal of Colorectal Disease. https://doi.org/10.1007/s00384-023-04530-6

Vancouver

Liao H, Li T, Liang Y, Liu Y, Yuan Y, Li M, et al. The benefits of adjuvant chemotherapy are associated with the kind of neoadjuvant therapy in stage ypI rectal cancer: evidence based on population analysis. International Journal of Colorectal Disease. 2023. doi:10.1007/s00384-023-04530-6

BibTeX
@article{Liao2023,
  author = {Liao, Hualin and Li, Tao and Liang, Yahang and Liu, Yaxiong and Yuan, Yuli and Li, Mingming and Li, Aidi and Liu, Yang and Yao, Yao and Li, Taiyuan},
  title = {The benefits of adjuvant chemotherapy are associated with the kind of neoadjuvant therapy in stage ypI rectal cancer: evidence based on population analysis},
  journal = {International Journal of Colorectal Disease},
  year = {2023},
  doi = {10.1007/s00384-023-04530-6}
}
Kostenlos starten →